Environmental Assessment of Sleep in Youth (EASY)

June 17, 2023 updated by: Wanda Phipatanakul, Boston Children's Hospital

Environmental Risk Factors for Pediatric Sleep Disordered Breathing

In this research study, investigators want to learn more about the factors that influence children's breathing during sleep and their sleep quality. Specifically, investigators are interested in factors that are related to risk of snoring, sleep apnea (a condition where breathing stops during sleep), and poor sleep quality.

Study Overview

Detailed Description

Investigators are doing a research study to gather information to help better understand why snoring and sleep problems are so common in the community, and how the home and neighborhood environment impacts sleep in children. Investigators want to know if factors such as the quality of air, household dust, environmental noise, and family routines impact sleep and other health and behavioral factors associated with sleep.

Investigators want to test how sleep is influenced by factors such as: the quality of air inside and outside the child's home (including measuring pollution, second hand smoke, and dust); temperature and humidity; family routines and interactions; and characteristics of the home. Investigators will ask participants to come in for a one time visit for undergoing procedures as well as answering questions regarding general health, asthma and sleep. 10% of the participating children will have a second home assessment and sleep monitoring procedures performed 6 months after the initial home assessment.

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Boston Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Children 6-12 years old who live in the Boston area.

Description

Inclusion Criteria:

  • Age 6-12 years
  • Children living (50% of the time or more) at their current residence for at least 1 month

Exclusion Criteria:

  • Children with severe chronic diseases (e.g. cancer, genetic or congenital disorders interfering with mobility)
  • Children with severe neurobehavioral, neurodevelopmental or psychiatric disorders requiring special assistance
  • Children living in the current residence for < 1 month will be not be eligible.
  • Families who do not speak English or Spanish well enough to complete the neuropsychological measures, as validated versions in other languages are not available for all of the measures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Apnea Hypopnea Index (AHI)
Time Frame: 2 days
Oxygen Desaturation Index (ODI; >3%desaturation dips) registered in the WatchPAT. Estimated Apnea and Hypopnea Indices, % recording time snoring using the EMFIT QS under mattress sensor.
2 days
Apnea Hypopnea Index (AHI)
Time Frame: 7days
Estimated Apnea and Hypopnea Indices, % recording time snoring using the EMFIT QS under mattress sensor.
7days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sleep duration and sleep efficiency
Time Frame: 7 days
average of the sleep sensor readings
7 days
Sleepiness Quality of Life
Time Frame: 7 days
total score of Epworth Sleepiness Scale(ESS)
7 days
Quality of Life score
Time Frame: 7 days
total score of Pediatric Quality of Life (PedsQL) (0-100) 100 is better outcome
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wanda Phipatanakul, MS. MS., Boston Children's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2018

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

June 17, 2023

Study Registration Dates

First Submitted

July 17, 2017

First Submitted That Met QC Criteria

July 19, 2017

First Posted (Actual)

July 21, 2017

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 17, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Environmental Exposure

3
Subscribe